
Tuesday, June 28, 2022 4:02:31 PM
Transgene and BioInvent Announce Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate BT-001 in Combination with KEYTRUDA®
June 28, 2022 02:00 AM Eastern Daylight Time
https://www.businesswire.com/news/home/20220627005554/en/Transgene-and-BioInvent-Announce-Clinical-Trial-Collaboration-and-Supply-Agreement-with-MSD-to-Evaluate-BT-001-in-Combination-with-KEYTRUDA%C2%AE
My posts are, will always be, and has always been in my own opinion. Do your own Due Diligence.
FEATURED Cannabix's MSBS Marijuana Breathalyzer Technology Advances Quantification of THC in Breath • Oct 3, 2023 8:50 AM
Strategic Joint Venture Signed by Santo Mining Corp. and Planta Vida S.A.S. • SANP • Oct 3, 2023 3:00 PM
Good Gaming, Inc. Announces Galactic Acres™ as Its First Mobile Game Integrated with Web3 Technology • GMER • Oct 3, 2023 8:30 AM
HealthLynked Announces Patent Filing for ARI: A Revolutionary AI-Powered Healthcare Interface • HLYK • Oct 3, 2023 8:00 AM
Nate's Food Co Successfully Completes Cancellation of 1 Billion Common Shares, Paving the Way for a Bright Future • NHMD • Oct 3, 2023 8:00 AM
Branded Legacy Expands Facility to 11,000 Sqft, Extends LOI for Acquisition of The Alcannabist LLC • BLEG • Oct 3, 2023 8:00 AM